Assessment of a mouse model of neutropenia and the effect of an anti- candidiasis monoclonal antibody in these animals

Journal of Infectious Diseases

Volumn 175, Issue 5, 1997, Pages 1169-1175

  Han, Yongmoon ^a   Cutler, Jim E ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B 6.1; MONOCLONAL ANTIBODY RB 6 8 C 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INFECTION RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0010206966     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516455     Document Type: Article

References (15)

1. British Society for Antimicrobial Chemotherapy. Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994;20:522-8.
2. Pfaller MA. Epidemiology of candidiasis. J Hosp Med 1995;30:329-38.
3. Slavin MA, Osborne B. Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a pro-spective, randomized, double-blind study. J Infect Dis 1995;171:1545-52.
4. de Pauw BE, Raemaekers JMM, Donnelly JP, Kullberg BJ, Meis JFGM. An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Ann Hematol 1995;70:83-7.
5. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1-8.
6. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 1995;35:103-14.
7. Denning DW. Can we prevent azole resistance in fungi. Lancet 1995;346:454-5.
8. Anttila VJ, Ruutu P, Bondestam S, et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 1994;18:979-81.
9. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-90.
10. Jahnson L, Chryssanthou E, Petrini B, Vikerfors T. Fluconazole failure in two cases of disseminated candidosis. Scan J Infect Dis 1995;27:421-4.
11. Banerjee U, Mohapatra LN, Kumar R. Role of antibody in defence against murine candidosis. Indian J Med Res 1984;79:760-5.
12. LaForce FM, Mills DM, Iverson K, Cousins R, Everett ED. Inhibition of leukocyte candidacidal activity by serum from patients with disseminated candidiasis. J Lab Clin Med 1975;86:657-66.
13. Walker SM, Urbaniak SJ. A serum-dependent defect of neutrophil function in chronic mucocutaneous candidiasis. J Clin Pathol 1980;33:370-2.
14. Witkin SS. Inhibition of Candida induced lymphocyte proliferation by antibody to Candida albicans. Obstet Gynecol 1986;68:696-9.
15. Tavares D, Ferreira P, Vilanova M, Videira A, Arala-Chaves M. Immunoprotection against systemic candidiasis in mice. Int Immunol 1995;7:785-96.